Novo Nordisk CEO wins 13% raise for 2023 (NYSE:NVO) Finances February 7, 2024 [ad_1] Tim de Waele/Velo by way of Getty Photographs Novo Nordisk’s (NVO) has granted its CEO Lars Fruergaard Jørgensen a…
New weight loss therapies can burden Medicare – experts (NYSE:NVO) Markets March 12, 2023 [ad_1] imyskin/iStock through Getty Photos New weight reduction therapies might trigger a major pressure on Medicare because of value implications,…
